PT1231908E - Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia - Google Patents
Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapiaInfo
- Publication number
- PT1231908E PT1231908E PT00951577T PT00951577T PT1231908E PT 1231908 E PT1231908 E PT 1231908E PT 00951577 T PT00951577 T PT 00951577T PT 00951577 T PT00951577 T PT 00951577T PT 1231908 E PT1231908 E PT 1231908E
- Authority
- PT
- Portugal
- Prior art keywords
- therapy
- pharmaceutical composition
- composition understanding
- compound
- breaking compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 2
- 108010029485 Protein Isoforms Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9907442A FR2794647A1 (fr) | 1999-06-11 | 1999-06-11 | Compositions pharmaceutique comprenant du no ou au moins un compose capable de liberer ou d'induire la formation de no dans les cellules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1231908E true PT1231908E (pt) | 2004-06-30 |
Family
ID=9546698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00951577T PT1231908E (pt) | 1999-06-11 | 2000-06-09 | Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6872751B2 (pt) |
| EP (1) | EP1231908B1 (pt) |
| JP (1) | JP2003506320A (pt) |
| AT (1) | ATE259223T1 (pt) |
| AU (1) | AU776692B2 (pt) |
| CA (1) | CA2376302A1 (pt) |
| DE (1) | DE60008293T2 (pt) |
| DK (1) | DK1231908T3 (pt) |
| ES (1) | ES2213032T3 (pt) |
| FR (1) | FR2794647A1 (pt) |
| PT (1) | PT1231908E (pt) |
| WO (1) | WO2000076451A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2847817B1 (fr) * | 2002-11-28 | 2006-11-10 | Centre Nat Rech Scient | Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires |
| CA2515929C (en) * | 2003-02-14 | 2013-11-19 | Children's Hospital & Research Center At Oakland | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| US20070191377A1 (en) * | 2004-03-31 | 2007-08-16 | Nitromed, Inc. | Methods for treating blood disorders with nitric oxide donor compounds |
| JPWO2007020917A1 (ja) * | 2005-08-18 | 2009-02-26 | 国立大学法人徳島大学 | ユートロフィン産生の増強持続剤とこれを用いる加工食品 |
| EP2786749A1 (en) * | 2006-02-03 | 2014-10-08 | Nicox S.A. | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| US9452117B2 (en) * | 2011-06-01 | 2016-09-27 | The Charlotte-Mecklenburg Hospital Authority | Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| EP2837390A1 (en) * | 2013-08-15 | 2015-02-18 | Universitäts-Kinderspital beider Basel | Combined Pharmaceutical Preparation for Use in Treating Neuromuscular Disorders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09508097A (ja) * | 1993-11-02 | 1997-08-19 | アメリカ合衆国 | 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用 |
| WO1995028377A1 (en) * | 1994-04-18 | 1995-10-26 | Abbott Laboratories | Guanidine compounds as regulators of nitric oxide synthase |
| US5583101A (en) * | 1994-07-15 | 1996-12-10 | Harvard College | Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction |
| US6197745B1 (en) * | 1995-09-15 | 2001-03-06 | Duke University | Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| US6153186A (en) * | 1995-09-15 | 2000-11-28 | Duke University Medical Center | Red blood cells loaded with S-nitrosothiol and uses therefor |
| US5789442A (en) * | 1996-01-18 | 1998-08-04 | Schering Aktiengesellschaft | Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
| AU2208097A (en) * | 1996-03-08 | 1997-09-22 | Regents Of The University Of California, The | Muscular dystrophy, stroke, and neurodegenerative disease diagnosis and treatment |
| DE69736230T2 (de) * | 1996-04-05 | 2007-05-31 | The General Hospital Corp., Boston | Behandlung einer hämoglobinstörung |
| DE29709820U1 (de) * | 1996-06-10 | 1997-07-31 | NUTREND, s.r.o., Olomouc | Lebensmittel-Spezialzusatz |
| EP2292630B1 (en) * | 1996-09-27 | 2015-11-25 | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| NO310618B1 (no) * | 1997-04-10 | 2001-07-30 | Ono Pharmaceutical Co | Kondenserte piperidinforbindelser, fremstilling og anvendelse derav, samt preparater omfattende slike forbindelser |
| US6232336B1 (en) * | 1997-07-03 | 2001-05-15 | The United States Of America As Represented By The Department Of Health And Human Services | Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| CA2371927A1 (en) * | 1999-03-11 | 2000-09-14 | The University Of Manitoba | Nitric oxide manipulation of muscle satellite cell activation |
| US6472390B1 (en) * | 2001-11-13 | 2002-10-29 | Duke University | Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
-
1999
- 1999-06-11 FR FR9907442A patent/FR2794647A1/fr active Pending
-
2000
- 2000-06-09 DE DE2000608293 patent/DE60008293T2/de not_active Expired - Fee Related
- 2000-06-09 DK DK00951577T patent/DK1231908T3/da active
- 2000-06-09 AU AU64473/00A patent/AU776692B2/en not_active Ceased
- 2000-06-09 CA CA002376302A patent/CA2376302A1/fr not_active Abandoned
- 2000-06-09 ES ES00951577T patent/ES2213032T3/es not_active Expired - Lifetime
- 2000-06-09 EP EP20000951577 patent/EP1231908B1/fr not_active Expired - Lifetime
- 2000-06-09 WO PCT/FR2000/001612 patent/WO2000076451A2/fr active IP Right Grant
- 2000-06-09 AT AT00951577T patent/ATE259223T1/de not_active IP Right Cessation
- 2000-06-09 PT PT00951577T patent/PT1231908E/pt unknown
- 2000-06-09 JP JP2001502791A patent/JP2003506320A/ja active Pending
-
2002
- 2002-04-29 US US10/133,435 patent/US6872751B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6872751B2 (en) | 2005-03-29 |
| ATE259223T1 (de) | 2004-02-15 |
| EP1231908B1 (fr) | 2004-02-11 |
| EP1231908A2 (fr) | 2002-08-21 |
| DK1231908T3 (da) | 2004-06-14 |
| US20020164383A1 (en) | 2002-11-07 |
| ES2213032T3 (es) | 2004-08-16 |
| FR2794647A1 (fr) | 2000-12-15 |
| WO2000076451A3 (fr) | 2002-06-20 |
| AU776692B2 (en) | 2004-09-16 |
| AU6447300A (en) | 2001-01-02 |
| WO2000076451A2 (fr) | 2000-12-21 |
| DE60008293T2 (de) | 2005-01-13 |
| JP2003506320A (ja) | 2003-02-18 |
| CA2376302A1 (fr) | 2000-12-21 |
| DE60008293D1 (de) | 2004-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002541T2 (tr) | Topiramatın farmasötik bilişimi | |
| DE69930739D1 (de) | Transdermale verwendung von sekretin zur behandlung von autismus | |
| MXPA03003960A (es) | Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos. | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE60222137D1 (de) | Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| BG101118A (en) | Therapeutical compounds | |
| NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| AU4727889A (en) | A novel purified thrombomodulin-like glycoprotein obtained from urine. | |
| PT1231908E (pt) | Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia | |
| WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
| BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
| ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| ATE326954T1 (de) | Transdermales therapeutisches system zur verabreichung von calciumantagonisten | |
| HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
| FR2759586B1 (fr) | Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol | |
| HUP0105412A2 (hu) | 3-Izoxazolidinon- és karboxi-alkil-hidroxámsav-származékok alkalmazása fertőzések kezelésére szolgáló gyógyszerkészítmények előállítására | |
| UA31379A (uk) | Спосіб лікування ішемічної хвороби серця | |
| ATE224730T1 (de) | Mittel zur behandlung von pigmentierungsstörungen | |
| UA32111A (uk) | Спосіб одержання препарату для лікування захворювань опорно-рухового апарату |